
Sunday, June 02, 2024 1:30:02 PM
Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
I think she has been buying on the decline
She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
There are about a dozen, if not more, listed gene editing companies
Not all will make it before they run out of money and have to raise more operating capital
Notice the $2 to $4 bounces on the way to lower lows

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Volume: | 367,867 |
Day Range: | 1.73 - 1.835 |
Bid: | 1.79 |
Ask: | 1.80 |
Last Trade Time: | 10:25:17 AM EDT |
Total Trades: | 1,678 |
Recent PRME News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 01:16:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 01:15:39 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/28/2025 01:21:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2025 01:13:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 01:02:28 PM
- Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 02/28/2025 01:00:00 PM
- Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference • GlobeNewswire Inc. • 02/24/2025 01:00:00 PM
- Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm • PR Newswire (US) • 01/30/2025 05:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:01:07 PM
- Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2025 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/23/2024 05:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/13/2024 01:18:34 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/22/2024 10:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:06:21 PM
- Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/12/2024 09:00:00 PM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:04:24 PM
- Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 11:38:53 AM
- Prime Medicine Unveils Strategically Focused Pipeline • GlobeNewswire Inc. • 09/30/2024 11:01:00 AM
- Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:26:47 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM
$PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection Market • NRXS • Mar 11, 2025 10:30 AM